Researchers at the Peter MacCallum Cancer Centre in Australia said the use of PET/CT imaging in evaluating patients with advanced lung cancer helped pave the way for significant survival gains. Data gathered from PET/CT scans allowed for tailored treatment that led to a 32% four-year survival rate, up from 10% to 20%. The finding indicates that PET/CT has potential for routine clinical use and that it could also be explored for other cancers, including head and neck cancers, melanoma and some bowel cancers, a researcher said.
Researchers tout PET/CT use in lung cancer treatment
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||